Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $102,866 | 59 | 67.6% |
| Consulting Fee | $22,733 | 18 | 14.9% |
| Travel and Lodging | $18,162 | 55 | 11.9% |
| Food and Beverage | $8,345 | 321 | 5.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $144,225 | 263 | $0 (2024) |
| Allergan, Inc. | $3,692 | 8 | $0 (2022) |
| PFIZER INC. | $1,234 | 90 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $619.27 | 27 | $0 (2022) |
| Medtronic, Inc. | $570.53 | 2 | $0 (2023) |
| Amgen Inc. | $432.23 | 16 | $0 (2024) |
| Lilly USA, LLC | $283.29 | 14 | $0 (2024) |
| Novo Nordisk Inc | $151.28 | 9 | $0 (2024) |
| Indivior Inc. | $150.02 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $106.26 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $42,455 | 149 | ABBVIE INC. ($41,361) |
| 2023 | $66,554 | 163 | ABBVIE INC. ($65,657) |
| 2022 | $27,815 | 108 | ABBVIE INC. ($22,680) |
| 2021 | $15,281 | 33 | AbbVie Inc. ($14,526) |
All Payment Transactions
453 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,005.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: VACCINES | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: PAIN | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $4.85 | General |
| Category: PAIN | ||||||
| 12/05/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $8.73 | General |
| Category: PAIN | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/13/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $502.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $4.31 | General |
| Category: PAIN | ||||||
| 11/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: PAIN | ||||||
| 10/28/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $3.49 | General |
| Category: PAIN | ||||||
| 10/17/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: PAIN | ||||||
| 10/16/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,005.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,005.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $29.29 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/11/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $91.55 | General |
| Category: Hematology | ||||||
| 10/11/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: PAIN | ||||||
| 10/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Central Nervous System | ||||||
| 10/09/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: VACCINES | ||||||
| 10/03/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: PAIN | ||||||
| 09/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 247 | 342 | $20,755 | $6,457 |
| 2021 | 4 | 59 | 152 | $34,960 | $8,819 |
| 2020 | 14 | 515 | 11,744 | $469,076 | $144,465 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 52 | $7,463 | $2,646 | 35.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 32 | $4,096 | $1,297 | 31.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 17 | 17 | $2,900 | $959.66 | 33.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 25 | 26 | $1,560 | $427.96 | 27.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 32 | 33 | $1,518 | $341.55 | 22.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 25 | 26 | $1,430 | $341.12 | 23.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 28 | 29 | $928.00 | $220.69 | 23.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 36 | 39 | $156.00 | $152.88 | 98.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 88 | $704.00 | $70.23 | 10.0% |
| J0475 | Injection, baclofen, 10 mg | Office | 2021 | 12 | 57 | $23,598 | $7,455 | 31.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 15 | $1,560 | $678.92 | 43.5% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 15 | 22 | $9,106 | $649.26 | 7.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 17 | 58 | $696.00 | $36.30 | 5.2% |
| J0475 | Injection, baclofen, 10 mg | Office | 2020 | 34 | 422 | $174,708 | $57,287 | 32.8% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 18 | 10,401 | $83,208 | $47,139 | 56.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 156 | 211 | $21,944 | $9,044 | 41.2% |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | Office | 2020 | 12 | 61 | $27,633 | $6,840 | 24.8% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Office | 2020 | 35 | 103 | $25,750 | $5,823 | 22.6% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 41 | 97 | $44,902 | $4,666 | 10.4% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2020 | 19 | 55 | $47,465 | $4,602 | 9.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 73 | 73 | $13,505 | $4,287 | 31.7% |
| 20553 | Injections of trigger points in 3 or more muscles | Office | 2020 | 19 | 31 | $10,974 | $1,173 | 10.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 13 | 13 | $3,445 | $1,166 | 33.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 19 | 19 | $2,869 | $987.06 | 34.4% |
| 20552 | Injections of trigger points in 1 or 2 muscles | Office | 2020 | 16 | 24 | $7,128 | $771.25 | 10.8% |
About Anna Short, ARNP
Anna Short, ARNP is a Physical Medicine & Rehabilitation healthcare provider based in Roeland Park, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/29/2010. The National Provider Identifier (NPI) number assigned to this provider is 1033428735.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anna Short, ARNP has received a total of $152,105 in payments from pharmaceutical and medical device companies, with $42,455 received in 2024. These payments were reported across 453 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($102,866).
As a Medicare-enrolled provider, Short has provided services to 821 Medicare beneficiaries, totaling 12,238 services with total Medicare billing of $159,741. Data is available for 3 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Other Specialties Nurse Practitioner
- Location Roeland Park, KS
- Active Since 09/29/2010
- Last Updated 11/02/2022
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1033428735
Products in Payments
- BOTOX (Biological) $68,230
- QULIPTA (Drug) $42,607
- UBRELVY (Drug) $28,124
- NURTEC ODT (Drug) $1,719
- SYNCHROMED (Device) $480.00
- Aimovig (Biological) $269.97
- EMGALITY (Drug) $180.13
- Prolia (Biological) $125.00
- VRAYLAR (Drug) $114.89
- BREZTRI (Drug) $106.26
- Kerendia (Drug) $104.25
- REXULTI (Drug) $100.49
- ACCRUFER (Drug) $91.55
- INTELLIS ADAPTIVESTIM (Device) $90.53
- Rybelsus (Drug) $82.08
- ELIQUIS (Drug) $80.81
- VYEPTI (Biological) $80.37
- TRULICITY (Drug) $68.61
- PREVNAR 20 (Biological) $53.42
- Ozempic (Drug) $49.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.